CYBB, cytochrome b-245 beta chain, 1536

N. diseases: 343; N. variants: 75
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.060 Biomarker disease BEFREE Insight into metabolic-inflammatory interface suggests that G6PD and NOX2 are potential therapeutic targets for PD. 31805953 2019
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.060 AlteredExpression disease BEFREE An analysis involving ERK1/2 siRNA revealed that simvastatin can inhibit NOX2 expression via the activation of ERK1/2 in the MPP+-treated PD cell model. 30513525 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.060 Biomarker disease BEFREE Taken together, our results showed that CR3 regulated Nox2 activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway in a two pesticide-induced PD model, providing novel insights into the immune pathogenesis of PD. 28978491 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.060 Biomarker disease BEFREE Our findings revealed that HD exposure damaged nigrostriatal dopaminergic system through α<sub>M</sub>β<sub>2</sub>-NOX2 axis-mediated microglial activation, providing, for the first time, experimental evidence for n-hexane exposure contributing to the etiology of PD. 29352205 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.060 Biomarker disease BEFREE To further explore a possible link between NADPH oxidase 2 (NOX2) and NOD2 signaling in PD, microglia were transfected with shRNA specific to NOX2 in vitro and apocynin were given to mice subjected to 6-OHDA and muramyl dipeptide (MDP) striatal injection. 30157869 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.060 Biomarker disease BEFREE The activation of microglial NADPH oxidase (NOX2) induced by α-synuclein has been implicated in Parkinson's disease (PD) and other synucleinopathies. 29154191 2018